Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2020-04-14 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming compliance related to securities dematerialization for the quarter ended 31st March 2020. It is addressed to stock exchanges and includes a confirmation from the Registrar and Share Transfer Agent. The document is a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is also not an announcement of a report publication but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and certifications that do not fit other categories.
2020-04-14 English
The details of securities dematerialized during the quarter ended 31st March 2020, has been submitted by Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming compliance related to securities dematerialization for the quarter ended 31st March 2020. It is addressed to stock exchanges and includes a confirmation certificate from the Registrar and Share Transfer Agent. The document is a compliance certificate and does not contain financial statements, management discussion, or detailed financial data. It is a regulatory compliance filing related to securities processing rather than a financial report or announcement of voting results, management changes, or capital changes. The document is relatively short (4632 characters) and serves as a formal attestation of regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and regulatory announcements that do not fit other specific categories.
2020-04-14 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 30 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, dated April 2, 2020. It details the shareholding of promoters in Sanofi India Limited as of March 31, 2020. The content includes specific shareholding percentages and names of promoters and persons acting in concert. This matches the description of a Major Shareholding Notification, which involves notification of changes or status in significant share ownership levels. The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding. Therefore, the correct classification is Major Shareholding Notification (MRQ). The document length is 3423 characters, which is consistent with a detailed notification rather than a brief announcement or a full report.
2020-04-03 English
Cessation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges about the cessation of the term of an Independent Director, Mr. Rangaswamy R. Iyer, on completion of his five-year term. It does not contain financial data, audit information, or any report content. It is an announcement related to changes in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this management change, confirming the classification.
2020-03-31 English
Mr. Rangaswamy R. Iyer was appointed as an Independent Director of the Company to hold office for a term of five years from 31st March 2015 to 30th March 2020. On completion of ....
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges about the cessation of the term of an Independent Director, Mr. Rangaswamy R. Iyer, on completion of his five-year term. It does not contain financial data, audit information, or any report content. It is an announcement related to a change in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this management change.
2020-03-31 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about a change in the closing date of a previously announced transaction involving a slump sale and transfer of a manufacturing facility. It references prior shareholder approval and regulatory approvals but does not contain financial statements or detailed financial data. The document is an update on a transaction timeline rather than the transaction announcement itself or a detailed report. It is a regulatory announcement informing the market about a delay in closing the transaction. Given the content and length (1967 characters), it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance updates that do not fit other specific categories.
2020-03-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.